This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The award, valued at $2,923.49, is a firm fixed-price delivery order contract with a completion date of December 10, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The DLA, as a defense agency, procures medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other essential medical supplies, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/10/25, 9:55 AM